Mechanistically, they linked the Smurf1 pro-oncogenic activities with the ability of Smurf1 to negatively regulate the expression of DAB2IP, a GTPase-activating protein (GAP) and a suggested tumor suppressor (86). The gene discussed is SMURF1; the disease is neoplasm.